Evidence-based review of the pharmacoeconomics related to the management of chronic nonmalignant pain

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 24, Issue 2, 2010, Pages 152-156

  Gupta, Anita ^a   Mehdi, Amna ^b   Duwell, Monique ^c   Sinha, Ashish ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chronic pain; Costs; Health care utilization; Nonmalignant pain; Opioids; Pharmacoeconomics; Work loss

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUPUNCTURE; ANALGESIA; BACKACHE; CHRONIC PAIN; CONSULTATION; DOSE RESPONSE; DRUG COST; DRUG MEGADOSE; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; FAILED BACK SURGERY SYNDROME; FEEDBACK SYSTEM; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTERDISCIPLINARY COMMUNICATION; INTRACTABLE PAIN; LOW DRUG DOSE; MASSAGE; MEDICAL CARE; MEDITATION; PSYCHOEDUCATION; PSYCHOSOCIAL CARE; SHORT SURVEY; SPINAL CORD STIMULATION;

ANALGESICS; CHRONIC DISEASE; COST OF ILLNESS; COST SAVINGS; COSTS AND COST ANALYSIS; ECONOMICS, PHARMACEUTICAL; EVIDENCE-BASED MEDICINE; HUMANS; PAIN;

EID: 77953003149     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.3109/15360281003713826     Document Type: Short Survey

References (16)

1. Verhaak P F M, Kerssens JJ, Dekker J, et al. Prevalence of chronic benign pain disorder among adults: a review of the literature. Pain. 1998;77:231-239.
2. Turk D. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain. 2002;18:355-365.
3. Hu XH, Markson LE, Lipton RB, et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159:813-818.
4. Sleed M, Eccleston C, Beecham J, et al. The economic impact of chronic pain in adolescence: methodological considerations and a preliminary costs-of-illness study. Pain. 2005;119:183-190.
5. Ferrell BR, Rhiner M. Use of technology in the management of cancer pain. J Pharmaceut Care Pain Symptom Control. 1994;2:17-35.
6. Whedon M, Ferrell BF. Professional and ethical considerations in the use of high-tech pain management. Oncol Nurs Forum. 1991;18:1135-1143.
7. Ferrell BR, Griffth H. Report from the Cancer Pain Panel of the Agency for Health Care Policy and Research. J Pain Symptom Manage. 1994;9:221-234.
8. Brown LD, Creswell S. Patient controlled analgesia: an evaluation. Hosp Pharm. 1988;23:144-152.
9. Bruera E. Ambulatory infusion devices in the continuing care of patients with advanced diseases. J Pain Symptom Manage. 1990;5:287-296.
10. Joranson DE. Availability of opioids for cancer pain: recent trends, assessment of system barriers, new World Health Organization guidelines, and the risk of diversion. J Pain Symptom Manage. 1994:8: 353-360.
11. Cicero TJ, Wong G, Tian Y, et al. Co-morbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database Pain. 2009;144:20-27.
12. Dillie KS, Fleming MF, Mundt MP, et al. Quality of life associated with daily opioid therapy in a primary care chronic pain sample. J Am Board Fam Med. 2008;21:108-117.
13. Pizzi LT, Carter CT, et al. Work loss, healthcare utilization, and costs among US employees with chronic pain. Dis Manage Health Outcomes. 2005;13:201-208.
14. Watkins EA, Wollan PC, Melton LJ 3rd, Yawn BP. A population in pain: report from the Olmsted County health study. Pain Med. 2008;9:166-174.
15. American Pain Foundation. Overview of American pain surveys: 2005-2006. J Pain Palliat Care Pharmacother. 2008;22:33-38.
16. Watkins E, Wollan PC, Melton LJ 3rd, Yawn BP. Silent pain sufferers. Mayo Clin Proc. 2006;81:167-171.